Exhibit 107
Calculation of Filing Fee Table
SC TO-I
(Form Type)
PharmaCyte Biotech, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1 – Transaction Valuation
Transaction Valuation |
Fee Rate |
Amount of Filing Fee | ||||
Fees to Be Paid | $25,187,500.00(1) | 0.00011020 | $2,775.66(2) | |||
Fees Previously Paid | — | — | — | |||
Total Transaction Valuation | $25,187,500.00(1) | |||||
Total Fees Due for Filing | $2,775.66 | |||||
Total Fees Previously Paid | — | |||||
Total Fee Offsets | — | |||||
Net Fee Due | $2,775.66 |
(1) | The transaction valuation is estimated only for purposes of calculating the filing fee. This amount is based on the purchase of 7,750,000 shares of common stock, par value $0.0001 per share, at the tender offer price of $3.25 per share. |
(2) | The amount of the filing fee, calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, equals $110.20 per $1,000,000 of the aggregate amount of the Transaction Valuation (or 0.01102% of the aggregate Transaction Valuation). The Transaction Valuation set forth above was calculated for the sole purpose of determining the filing fee and should not be used for any other purpose. |